Launched in 2023 to prevent cervical cancer, India’s first indigenous human papilloma virus (HPV) vaccine—Cervavac ... by Serum Institute Of India (SII) in collaboration with central ...

Cervical cancer is the fourth most common cancer ... a further breakthrough was achieved as the Serum Institute of India (SII) launched its HPV vaccine, Cervavac. Production of the vaccine began ...

Cervical cancer, which is the ... to the Serum Institute of India (SII) to manufacture indigenously-developed India’s first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical ...

The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.

Cervavac was developed by Serum Institute Of India (SII) in collaboration ... in 2023 to prevent cervical cancer, India’s first indigenous human papilloma virus (HPV) vaccine—Cervavac ...